Furthermore, Zhao et al. provided evidence that the expression of macrophage migration inhibitory factor (MIF) in tumors was positively correlated with plasma MIF levels, which had a higher value for the diagnosis of HCC compared to serum a-fetoprotein (AFP). This evidence concerns the gene MIF and hepatocellular carcinoma.